Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discordances originated by multiple meta-analyses on interventions for myocardial infarction: a systematic review.
Lucenteforte E, Moja L, Pecoraro V, Conti AA, Conti A, Crudeli E, Galli A, Gensini GF, Minnelli M, Mugelli A, Proietti R, Shtylla J, D'Amico R, Parmelli E, Virgili G. Lucenteforte E, et al. Among authors: moja l. J Clin Epidemiol. 2015 Mar;68(3):246-56. doi: 10.1016/j.jclinepi.2014.11.004. Epub 2014 Nov 13. J Clin Epidemiol. 2015. PMID: 25533151 Free article. Review.
Multiple systematic reviews: methods for assessing discordances of results.
Moja L, Fernandez del Rio MP, Banzi R, Cusi C, D'Amico R, Liberati A, Lodi G, Lucenteforte E, Minozzi S, Pecoraro V, Virgili G, Parmelli E. Moja L, et al. Intern Emerg Med. 2012 Dec;7(6):563-8. doi: 10.1007/s11739-012-0846-1. Epub 2012 Sep 2. Intern Emerg Med. 2012. PMID: 22941412 Review.
Heterogeneity and meta-analyses: do study results truly differ?
Virgili G, Conti AA, Moja L, Gensini GF, Gusinu R. Virgili G, et al. Among authors: moja l. Intern Emerg Med. 2009 Oct;4(5):423-7. doi: 10.1007/s11739-009-0296-6. Intern Emerg Med. 2009. PMID: 19714444 Free article. No abstract available.
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration.
Moja L, Lucenteforte E, Kwag KH, Bertele V, Campomori A, Chakravarthy U, D'Amico R, Dickersin K, Kodjikian L, Lindsley K, Loke Y, Maguire M, Martin DF, Mugelli A, Mühlbauer B, Püntmann I, Reeves B, Rogers C, Schmucker C, Subramanian ML, Virgili G. Moja L, et al. Cochrane Database Syst Rev. 2014 Sep 15;9(9):CD011230. doi: 10.1002/14651858.CD011230.pub2. Cochrane Database Syst Rev. 2014. PMID: 25220133 Free PMC article. Review.
198 results